In this month’s update, Dr. Tracy Pfeifer highlights all our webinars, like Master Class and AlliedPro Forum, all the travels from New York to Florida, recapping the Facial and Rhinoplasty Symposium and the upcoming The MEET 2026 in Boston!
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and Sodium-glucose cotransporter 2 (SGLT-2) inhibitors are widely used for Type 2 diabetes and weight management but may adversely affect skin quality, resulting in dermal thinning, decreased elasticity, and accelerated aging—a phenomenon referred to as “GLP-1 Face.”
The recent Facial and Rhinoplasty Symposium was a tremendous success – and a great example of how The Society is evolving to meet the needs of our members and the demands of a fast-changing industry.
My theme for this year as President of The Aesthetic Foundation is “to make a difference”. The Foundation is in a unique position as the research, education, and charitable arm of The Aesthetic Society to achieve that goal.